| ACT 2008 is THE premier international event offering unparalleled networking and knowledge sharing by bringing together the most influential and respected scientists to cover the latest and most promising discoveries surrounding Assay & Screening Advances, GPCR, Protein Kinase, and Ion Channel Drug Targets. Featuring four comprehensive conference tracks: This intensive three-day event allows you access to over 75 presentations delivered by respected scientists from both industry and academia, as well as networking opportunities with over 200 professionals in the field. Opening Keynotes:  | The Challenges of Ion Channel Drug Discovery - Case Studies
Greg Kaczorowski, Ph.D., Senior Director, Ion Channel Department, Merck Research Laboratories |  | Classical Paradigms and the Shift in Conceptualization of GPCR Pharmacology
Paul A. Insel, M.D., Professor of Pharmacology & Medicine, Director, Medical Scientist Training Program, University of California, San Diego |  | Vision of the Future of Kinase Inhibitors in Drug Discovery
Peter Mueller, Ph.D., CSO & Executive Vice President Drug Innovation and Realization, Vertex Pharmaceuticals, Inc. |  | Industry Assessment of Current Screening Approaches and Future Outlook
Jeremy Caldwell, Ph.D.,Director of Molecular and Cell Biology, Genomics Institute of the Novartis Research Foundation | | Register Early and Save! Take advantage of early registration discounts.
Register Today IN THE NEWS ACT 2008 Speaker Stephen Sligar of University of Illinois, Urbana has been recognized as author of the most cited article published in Biochemistry in 2007. » View the complete list NEW THIS YEAR - Each conference will kickoff with an industry leader's keynote presentation providing a detailed assessment of the current industry landscape.
- Take part in one of four interactive ACT 2008 Scientific Advisory Board Panel Discussions
- Choose from three instructional pre-conference workshops on today's most advanced screening technologies
- Take part in one of four interactive ACT 2008 Scientific Advisory Board Panel Discussions
- Find out who the newly announced members of the Molecular Libraries Probe Production Centers Network are, and learn the very latest on the network's capabilities
Three Hands-On Pre-Conference Workshops Scientific Advisory Board Panel Discussions - Future of Kinase Inhibitors in Drug Discovery
- Target Centric vs. Systems Biology: Relative Value Development, Tools and Technologies
- Implications of Changing Paradigms in GPCR Signaling on Drug Discovery
- Opportunities and Challenges of Ion Channel Drug Discovery
|
Copyright IBC Life Sciences, a part of Informa Life Sciences Group